Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lung Neoplasms 3 Leukemia, Myelomonocytic, Juvenile 3 Head and Neck Neoplasms 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Recurrence 2 Neoplasms 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Medulloblastoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 HIV Infections 2 Ganglioneuroblastoma 2 Central Nervous System Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Brain Neoplasms 2 Acquired Immunodeficiency Syndrome 2 AIDS-Related Complex 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Dysplasia 1 Uterine Cervical Diseases 1 Tumor Virus Infections 1 Thrombocytopenia 1

Interventions

Ipilimumab 114 pembrolizumab 95 Nivolumab 91 aldesleukin 86 Interleukin-2 57 Cyclophosphamide 54 Dacarbazine 52 Vemurafenib 39 trametinib 37 Temozolomide 37 incomplete Freund's adjuvant 35 fludarabine phosphate 35 sargramostim 32 dabrafenib 32 fludarabine 26 Bevacizumab 26 Paclitaxel 22 MART-1 Antigen 21 Granulocyte-Macrophage Colony-Stimulating Factor 21 montanide ISA 51 20 Interferon-alpha 20 Cisplatin 20 Carboplatin 19 Sorafenib 18 Introns 17 Biopsy 17 cobimetinib 16 Radiosurgery 16 atezolizumab 15 Radiotherapy 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Melanoma × Isotretinoin × Clear all

NCT00025012 2013-06-19

Isotretinoin in Preventing Skin Cancer

National Cancer Institute (NCI)

Phase NA Completed

Carcinoma, Basal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡